اگلا

آٹو پلے

Priority Review in Merkel Cell Carcinoma, Breakthrough Designation in RET-Altered Cancers, and More

3 مناظر • 07/17/23
بانٹیں
ایمبیڈ
administrator
administrator
سبسکرائبرز
0

Gina Columbus reports on a priority review designation in Merkel cell carcinoma, a breakthrough therapy designation in select RET-altered cancers, an application submitted in pediatric ALL, and European approvals in multiple myeloma, melanoma, and ALL.

مزید دکھائیں
0 تبصرے sort ترتیب دیں
فیس بک کے تبصرے

اگلا

آٹو پلے